NIQ Report Reveals 2025 Global Health & Wellness Trends
28.5.2025 15:00:00 CEST | Business Wire | Press Release
NielsenIQ (NIQ) today launched its Global State of Health & Wellness 2025: Navigating the shift from health trends to lifestyle choices, the first report of its kind for NIQ to examine emerging consumer behaviors around health and wellness. The findings include regional deep dives in 19 countries, focusing on the critical topics of trust and influence, nutrition, weight loss, mental wellness, health technology, and conscious buying within health and wellness.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527155254/en/
According to NIQ, consumers are increasingly making choices for their future health—70% of global consumers believe they are proactive in managing their health and 57% now prioritize “aging well” more than they did five years ago. As a result, 55% of consumers are willing to spend over $100 a month on better nutrition, self-care, physical and mental health, and more. However, consumers are growing increasingly skeptical about health claims. Globally, 82% say labels on health and wellness products need to be more transparent and easier to understand, and 25% say that their lack of trust that wellness products or services will be effective is stopping them making healthier life choices.
“To thrive in the evolving wellness market, brands must go beyond product innovation to deliver clarity, transparency, affordability, and trust,” said Marta Cyhan-Bowles, Chief Communications Officer & Head of Global Marketing COE. “Consumers are ready to invest in their well-being but need guidance. Companies must ensure their products are accessible, transparently labeled, and competitively priced to win consumer loyalty.”
Top Consumer Trends in Health and Wellness in 2025
To capture shifting consumer preferences and what it means to live well, manufacturers and retailers must connect with today’s holistically minded and better-informed consumers in ways that focus on their priorities.
Nutrition and gut health are driving healthy food and beverage choices:
Half (53%) of the consumers across 19 surveyed countries say they plan to buy more high-fiber foods in 2025, while around 40% plan to buy more superfoods, high-protein plant-based foods, or probiotic foods.
Anti-obesity medications (AOMs) are transforming weight loss management:
More than half (54%) of consumers place more importance on healthy body weight, shape, and muscle tone now than they did five years ago. Four in 10 (43%) would consider taking AOMs if recommended by their healthcare provider, but 63% globally are not familiar with the medications.
Health-related technology is a growth area in the global Consumer Tech & Durables market:
Three-quarters (74%) of consumers would prefer a tech product with extra health and wellness features over one without. Nearly two-thirds (63%) believe that health-focused technology products are effective in helping to improve their health and wellness, and 57% say they would use an app or screening device that ensures the products they purchase align with their personal health priorities.
Consumers are focusing on self-care and wellness:
Nearly two-thirds (63%) of consumers prioritize getting quality sleep and looking after their mental health more than they did five years ago. They also plan to do more activities like spending time in nature (60%), massage and muscle relaxation (40%), yoga and meditation (35%), or aromatherapy (24%).
Conscious buying—the global demand for socially responsible products is on the rise:
Personal well-being and societal responsibility are becoming increasingly interlinked in consumers’ outlooks. In fact, 70% of surveyed consumers say they believe it’s “important” or “very important” that the health and wellness products they buy are also eco-friendly and/or ethically produced (e.g., fair trade, cruelty-free, higher animal welfare), and 71% are willing to pay more for wellness products with these attributes.
Key Takeaways for Brands
Manufacturers and retailers must address consumers’ ongoing core concerns around the cost and availability of healthier options—and their desire for authentic, clear, and detailed product information. Brands can additionally win loyalty with core segments, along with premiumization potential, by ensuring that their full product portfolio has a wellness focus, as well as being ethically sourced, environmentally responsible, and socially aware.
About the Global State of Health & Wellness 2025 Report
This flagship report focuses on global forces that are shaping consumers’ developing needs and findings around consumers’ health and wellness awareness, aspirations, motivations, barriers, and future buying intentions. To understand how these trends are impacting your local market, download a free copy of the global report and one or more of the five Regional Insights Companions that dig deeper into specific markets across Asia Pacific; Europe, Middle East & Africa; Latin America; North America; and Western Europe.
Research Methodology
NIQ’s 2025 Global Health & Wellness survey was conducted in January and February 2025. Nearly 19,000 adult consumers were interviewed online in the following 19 countries: Brazil, Canada, China, Czechia, France, Germany, Hungary, India, Indonesia, Italy, Mexico, Netherlands, Poland, South Africa, Spain, Turkey, United Arab Emirates, United Kingdom, and United States. Data reflects the adult grocery shopping population in each respective country.
About NIQ
NielsenIQ (NIQ) is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together two industry leaders with unparalleled global reach. Our global reach spans over 90 countries covering approximately 85% of the world’s population and more than $ 7.2 trillion in global consumer spend. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View™.
For more information, please visit www.niq.com
© 2025 Nielsen Consumer LLC. All Rights Reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250527155254/en/
Contacts
Patricia Ratulangi
patricia.ratulangi@nielseniq.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release
Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke
Digital Reef Turns to Vertical Farming to Reduce Data Centre Footprint in Partnership With Elevate Farms and Xange.com to Provide Digital Measurement, Reporting and Verification of Project's Environmental Impact Within the Reef Origin Ecosystem23.10.2026 13:12:00 CEST | Press Release
Elevate Farms Inc. and Digital Reef Ltd partnership supports mitigating environmental impact of global data centre expansion establishing a framework for Digital Reef’s infrastructure pipeline to support and utilize environmental assets generated by Elevate Farms' high-yield, closed-loop vertical farming operations. Traditional agriculture supply chains are replaced with optimized indoor facilities significantly reducing food production carbon emissions, water waste and local land constraints. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022393352/en/ Elevate Farms technology offers part of the solution to climate impact isolating food production from traditional agricultural farming variables saving over 95% of standard water requirements and significantly reducing farmland required for equivalent yields and logistical carbon. Digital Reef CEO Piers Slater stated "Digital Reef embrace data centre growth and environment
SLB Announces Third-Quarter 2026 Results23.10.2026 12:50:00 CEST | Press Release
SLB (NYSE: SLB) today announced results for the third-quarter 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261021694458/en/ The exterior of the SLB headquarters in Houston, Texas. Third-Quarter Results (Stated in millions, except per share amounts)Three Months EndedChangeSept. 30, 2026Jun. 30, 2026Sept. 30, 2025SequentialYear-on-yearRevenue $9,449 $8,972 $8,928 5% 6% Income before taxes - GAAP basis $1,019 $1,018 $1,000 0% 2% Income before taxes margin - GAAP basis 10.8% 11.4% 11.2% -57 bps -42 bps Net income attributable to SLB - GAAP basis $735 $786 $739 -6% -1% Diluted EPS - GAAP basis $0.49 $0.52 $0.50 -6% -2% Adjusted EBITDA* $2,067 $1,899 $2,061 9% - Adjusted EBITDA margin* 21.9% 21.2% 23.1% 71 bps -121 bps Pretax segment operating income* $1,576 $1,404 $1,626 12% -3% Pretax segment operating margin* 16.7% 15.6% 18.2% 104 bps -153 bps Net income attributable to SLB, excluding charges & credits* $962 $833 $1,027
EZVIZ’s Smart Entry Solutions Have Consecutively Clinched the European Product Design Award and the Golden Pin Design Award, Indicating a Shift From Home Security to Living Enjoyment23.10.2026 11:58:00 CEST | Press Release
EZVIZ’s smart lock and AI-powered doorbell remained in the spotlight after IFA for bagging two world-class awards. The EP8 Ultra AI-powered video doorbell won the European Product Design Award 2026 (EPDA 2026), keeping leading in user-centric AI. Meanwhile, the DL50FVX smart lock was named the 2026 Golden Pin Design Award (GPDA) laureate for its intuitive access management and entered the finalist of the Best Design Awards. The growing prestige of EZVIZ’s smart home access management lineup marks a new chapter of providing living experiences with multi-level interaction, modern aesthetics, and emotional care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022441786/en/ Two representative models from EZVIZ's smart entry family take home prestigious awards for user-centric innovation. Founded in 2016, the EPDA aims to recognize well-thought-out products that break with tradition and improve everyday life. Continually refres
Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines23.10.2026 07:00:00 CEST | Press Release
Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company’s Injectable Aesthetics portfolio in China – one of the world's largest and fastest-growing aesthetics markets.8,9 This approval follows successful authorizations and launches of Relfydess in more than 35 markets worldwide. Relfydess is the first and only ready-to-use liquid neuromodulator developed with PEARL Technology, designed to deliver a highly active, innovative, complex-free molecule that addresses the real needs of patients and healthcare professionals.1,2,4,5 It is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.1,10 At a time whenpatients and healthcare professionals are increasingly seeking high-performance neuromodulators that rapidly deliver long-lasting, natural-looking outcomes, Re
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom